OXYGEN THERAPY
Oxygen Therapy is a biopharma company that develops anti-necrosis drugs that treat a variety of medical conditions resulting from Ischemia. The company focuses on the development and commercialization of first-in-class treatments to prevent catastrophic brain damage resulting from hypoxic conditions following a brain stroke. The Company’s lead product candidate, OTI-629, is an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked. It will be tested as a potent resuscitative agent to treat Ischemic brain strokes, also known as Cardiac Cerebrovascular Accidents (CVA). In addition, their drug candidate OTI-1011, will be tested as a resuscitative agent in a variety of wound healing applications.
OXYGEN THERAPY
Industry:
Biopharma Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.otipharma.com
Total Employee:
11+
Status:
Closed
Contact:
617-454-1199
Email Addresses:
[email protected]
Total Funding:
300 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Euro
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.otipharma.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
